We are pleased to share an important milestone in the life of the geneTIGA project: the upcoming Final Meeting, which will take place in Rome on November 23–24, 2026.
The geneTIGA project will hold its Final Meeting in Rome on 23–24 November 2026, marking a key milestone in advancing European research in gene and cell therapy. The event will present the project’s final scientific results, with a strong focus on engineered T-cell approaches and next-generation gene editing strategies for immune-mediated diseases. Researchers, clinicians, and stakeholders will discuss how these breakthroughs can be translated into clinical applications and future therapeutic development pathways, while also fostering new collaborations across the European research landscape.
📍 Rome, Italy
📅 November 23–24, 2026
Registration will open soon.
In parallel, two new project videos are now online, offering an inside look at the people and science behind geneTIGA. Through short interviews, project coordinator Petra Reinke, along with Toni Catomen, Catherine Bull and Dimitrios Wagner, share insights into the project’s goals, interdisciplinary collaboration, and the integration of clinical expertise and technological innovation. A second video features Johanna Olweus, who reflects on recent achievements and outlines the next steps toward translating research into tangible clinical impact.
Both the Final Meeting and the new videos highlight geneTIGA’s commitment to advancing cutting-edge gene and cell therapy research, strengthening collaboration, and accelerating the path from discovery to patient benefit.